Evidence map›Paper›PMID 36645455›Full record

ArticleEuropean radiology2023

Distinguishing common renal cell carcinomas from benign renal tumors based on machine learning: comparing various CT imaging phases, slices, tumor sizes, and ROI segmentation strategies.

Tao Zhou, Jian Guan, Bao Feng, Huimin Xue, Jin Cui, Qionglian Kuang, Yehang Chen, Kuncai Xu, Fan Lin, Enming Cui and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Prospective evaluation ofAnnals of nuclear medicine · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. CT-based AI score associates with perioperative outcomes in nephron-sparing surgery for renal cell carcinoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  12. CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesions.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Tao Zhou *Department of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China.
Jian Guan *Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan Second Road, Guangzhou, 510000, People's Republic of China.
Bao FengDepartment of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China.
Huimin XueDepartment of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China.
Jin CuiDepartment of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China.
Qionglian KuangDepartment of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China.
Yehang ChenSchool of Electronic Information and Automation, Guilin University of Aerospace Technology, 2 Jinji Road, Guilin, 541000, People's Republic of China.
Kuncai XuSchool of Electronic Information and Automation, Guilin University of Aerospace Technology, 2 Jinji Road, Guilin, 541000, People's Republic of China.
Fan LinDepartment of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, 3002 SunGangXi Road, Shenzhen, 518035, People's Republic of China. foxetfoxet@gmail.com.
Enming CuiDepartment of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China. cem2008@163.com.
Wansheng LongDepartment of Radiology, Jiangmen Central Hospital, Guangdong Medical University, Zunyi Medical University, 23 Beijie Haibang Street, Jiangmen, 529030, People's Republic of China. jmlws2@163.com.ORCID http://orcid.org/0000-0002-1331-1858
Guangdong Medical College · CNSun Yat-sen University · CNGuilin University of Aerospace Technology · CNKey Laboratory of Guangdong Province · CNShenzhen University Health Science Center · CN

Funding

Guangdong Basic and Applied Basic Research Foundation 2021A1515220080Opening Research Fund of Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation 201905010003
6 · The paper itself

Abstract

objectivesTo determine whether a CT-based machine learning (ML) can differentiate benign renal tumors from renal cell carcinomas (RCCs) and improve radiologists' diagnostic performance, and evaluate the impact of variable CT imaging phases, slices, tumor sizes, and region of interest (ROI) segmentation strategies.

methodsPatients with pathologically proven RCCs and benign renal tumors from our institution between 2008 and 2020 were included as the training dataset for ML model development and internal validation (including 418 RCCs and 78 benign tumors), and patients from two independent institutions and a public database (TCIA) were included as the external dataset for individual testing (including 262 RCCs and 47 benign tumors). Features were extracted from three-phase CT images. CatBoost was used for feature selection and ML model establishment. The area under the receiver operating characteristic curve (AUC) was used to assess the performance of the ML model.

resultsThe ML model based on 3D images performed better than that based on 2D images, with the highest AUC of 0.81 and accuracy (ACC) of 0.86. All three radiologists achieved better performance by referring to the classifier's decision, with accuracies increasing from 0.82 to 0.87, 0.82 to 0.88, and 0.76 to 0.87. The ML model achieved higher negative predictive values (NPV, 0.82-0.99), and the radiologists achieved higher positive predictive values (PPV, 0.91-0.95).

conclusionsA ML classifier based on whole-tumor three-phase CT images can be a useful and promising tool for differentiating RCCs from benign renal tumors. The ML model also perfectly complements radiologist interpretations. KEY POINTS: • A machine learning classifier based on CT images could be a reliable way to differentiate RCCs from benign renal tumors. • The machine learning model perfectly complemented the radiologists' interpretations. • Subtle variances in ROI delineation had little effect on the performance of the ML classifier.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsDiagnosis, DifferentialHumansMachine LearningRetrospective StudiesTomography, X-Ray ComputedAngiomyolipomaArtificial intelligenceMachine learningOncocytomaRenal cell carcinoma

Identifiers

PMID36645455
OpenAlexW4316662391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.